Table 2

Base-case cost-effectiveness results for mild and moderate TBI patients treated with and without tranexamic acid in the UK and Pakistan

CostsLYsQALYsICER (LY)ICER (QALY)CE threshold (per QALY)Probability CE at threshold
UK
 Placebo£55 11016.8712.10
 Tranexamic acid£55 86917.1212.28£3078£4288£20 00099%
Pakistan
 PlaceboUS$9214.9710.83
 Tranexamic acidUS$9715.2611.04US$17US$24US$15898%
  • CE, cost-effectiveness; ICER, incremental cost-effectiveness ratio; LY, life-years; QALY, quality-adjusted life-years; TBI, traumatic brain injury.